Sanofi-aventis U.S joins Dispensary of Hope's Continued Access Program

The Dispensary of Hope is pleased to announce that sanofi-aventis U.S., the U.S. affiliate of sanofi-aventis, a leading global pharmaceutical company, has become the latest pharmaceutical company to participate in the Dispensary's Continued Access Program, which provides uninsured patients with access to medicines that they otherwise couldn't afford.

“Sanofi-aventis U.S. has a long track record of helping patients in need. We are pleased to join with the Dispensary of Hope's Continued Access Program to help the growing patient population who cannot afford their prescription medications”

As part of the Continued Access Program, sanofi-aventis U.S. will assist the Dispensary of Hope in providing access to prescription medications. Sanofi-aventis U.S. provides medications in a variety of therapeutic areas including cardiology, internal medicine, as well as diabetes which is one of the most common health issues facing the Dispensary of Hope patients.

"It is important to our organization to use every avenue possible as we work to provide our patients with medications that are needed for daily life, so to have sanofi-aventis U.S. join us as we strive to seek and dispense medications speaks highly of the company's commitment to help patients in need obtain quality prescription medication," said Scott Cornwell, chief operating officer of Dispensary for Hope.

"Sanofi-aventis U.S. has a long track record of helping patients in need. We are pleased to join with the Dispensary of Hope's Continued Access Program to help the growing patient population who cannot afford their prescription medications," said Anthony Piagentini, Senior Manager, Patient Assistance Programs for sanofi-aventis U.S.

Through innovative stewardship of the pharmaceutical supply-chain, the Dispensary of Hope has been able to develop a national distribution center and pharmacy to support a network of dispensing sites and direct-to-patient prescription solutions.